Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Argan (AGX) Short-term Investments (2016 - 2025)

Argan's Short-term Investments history spans 11 years, with the latest figure at $4.6 million for Q4 2025.

  • For Q4 2025, Short-term Investments fell 96.3% year-over-year to $4.6 million; the TTM value through Oct 2025 reached $4.6 million, down 96.3%, while the annual FY2025 figure was $153.1 million, 39.86% up from the prior year.
  • Short-term Investments for Q4 2025 was $4.6 million at Argan, down from $153.1 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $175.6 million in Q3 2022 and bottomed at $4.6 million in Q4 2025.
  • The 5-year median for Short-term Investments is $90.3 million (2021), against an average of $103.2 million.
  • The largest annual shift saw Short-term Investments skyrocketed 338.4% in 2022 before it plummeted 96.3% in 2025.
  • A 5-year view of Short-term Investments shows it stood at $90.0 million in 2021, then skyrocketed by 67.29% to $150.6 million in 2022, then dropped by 28.25% to $108.0 million in 2023, then rose by 15.24% to $124.5 million in 2024, then tumbled by 96.3% to $4.6 million in 2025.
  • Per Business Quant, the three most recent readings for AGX's Short-term Investments are $4.6 million (Q4 2025), $153.1 million (Q1 2025), and $124.5 million (Q4 2024).